Literature DB >> 8897575

Urinary beta 2-microglobulin as a marker for vesicoureteral reflux.

F K Assadi1.   

Abstract

To determine whether urinary beta 2-microglobulin (beta 2 M) excretion would be elevated in patients with severity of vesicoureteral reflux, urinary beta 2 M/creatinine (Cr) ratios were measured on random urine samples in 56 children with various grades of reflux. Results were compared with ratios of 39 nonrefluxing patients matched for age and gender. Patients with evidence of renal insufficiency or urinary tract infection were excluded. Bladder urine was obtained at the time of the vesicoureterogram. Reflux was graded using the International Reflux Classification System. The mean urinary beta 2 M/Cr ratio was higher in the refluxing group (1.82 +/- 0.6 micrograms/mg Cr) than in the nonrefluxing control group (0.54 +/- 0.09 microgram/mg Cr. P < 0.01). When the mean urinary beta 2 M/Cr ratios were compared for each grade of reflux with the nonrefluxing control group, patients with grade IV and V reflux had significantly higher urinary beta 2 M/Cr values than the nonrefluxing patients (2.83 +/- 0.71 micrograms/mg Cr and 4.61 +/- 0.65 micrograms/mg Cr, P < 0.001, respectively). No patient with grade I, II, or III reflux had a urinary beta 2 M/Cr ratio above 0.92 microgram/mg Cr. Statistical analysis revealed no significant differences among the mean beta 2 M/Cr ratio for grade I (0.53 +/- 0.08), II (0.51 +/- 0.09), or III (0.59 +/- 0.17) refluxers or the nonrefluxing controls. Therefore, urinary beta 2 M/Cr ratios are increased in children with a high grade of reflux. Such values may be useful in the early detection of tubular damage in patients with vesicoureteral reflux.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897575     DOI: 10.1007/s004670050180

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

1.  [Study on urinary low molecular protein and enzyme in primary vesico-ureteral reflux patients].

Authors:  M Takeda; Y Katayama; H Takahashi; T Imai; K Saito; S Sato
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1990-03

2.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

Review 3.  Beta 2-microglobulin: its significance in the evaluation of renal function.

Authors:  G H Schardijn; L W Statius van Eps
Journal:  Kidney Int       Date:  1987-11       Impact factor: 10.612

4.  A new perspective on the natural history of vesicoureteric reflux.

Authors:  B T Steele; J De Maria
Journal:  Pediatrics       Date:  1992-07       Impact factor: 7.124

5.  Reflux nephropathy secondary to intrauterine vesicoureteric reflux.

Authors:  A Najmaldin; D M Burge; J D Atwell
Journal:  J Pediatr Surg       Date:  1990-04       Impact factor: 2.545

6.  Renal handling of beta-2-microglobulin in neonates treated with gentamicin.

Authors:  F K Assadi; E Chow-Tung
Journal:  Nephron       Date:  1988       Impact factor: 2.847

Review 7.  Vesico-uretero-renal reflux and the kidney.

Authors:  H Olbing
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

8.  Development of new renal scars: a collaborative study.

Authors:  J M Smellie; P G Ransley; I C Normand; N Prescod; D Edwards
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-29

9.  Urinary beta 2 microglobulin in upper and lower urinary-tract infections.

Authors:  G Schardijn; L W Statius van Eps; A J Swaak; J C Kager; J P Persijn
Journal:  Lancet       Date:  1979-04-14       Impact factor: 79.321

10.  Beta 2-microglobulin clearance in neonates: index of tubular maturation.

Authors:  F K Assadi; E G John; P Justice; L Fornell
Journal:  Kidney Int       Date:  1985-08       Impact factor: 10.612

View more
  1 in total

1.  Urinary excretion of EGF and MCP-1 in children with vesicoureteral reflux.

Authors:  Valentina Pastore; Fabio Bartoli
Journal:  Int Braz J Urol       Date:  2017 May-Jun       Impact factor: 1.541

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.